Arcturus Therapeutics Holdings Inc (ARCT NASDAQ) stock market data APIs
$7.2584
0(0%)
as of February 4, 2026
Try our APIs with
free plan!
Arcturus Therapeutics Holdings Inc Financial Data Overview
Price chart is built with
Anychart
Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Prev. Close
7.2584
Open
7.3448
High
7.5723
Low
7.0846
52 wk Range
5.85-24.17
Market Cap
208 M
Shares Outstanding
28 414 K
Revenue
97 601 K
EPS
-0.49
Beta
2.429
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Arcturus Therapeutics Holdings Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Arcturus Therapeutics Holdings Inc data using free add-ons & libraries
Get Arcturus Therapeutics Holdings Inc Fundamental Data
Arcturus Therapeutics Holdings Inc Fundamental data includes:
- Net Revenue: 97 601 K
- EBITDA: -75 185 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-10
- EPS/Forecast: 5.53
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Arcturus Therapeutics Holdings Inc News
New
Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. The seventeenth stock on our list is Arcturus Therapeutics Holdings Inc. TheFly reported on January 22 that Roth Capita...
Arcturus Therapeutics Holdings (ARCT) Valuation Check As J.P. Morgan Healthcare Conference Presentation Nears
Arcturus Therapeutics Holdings (ARCT) is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. This event is a forum where management often outlines pipeline progres...
1 Under-$10 Stock Set to Surge as Much as 963% in 2026
Stocks trading under $10 rarely come with the potential for life-changing gains, especially in today’s cautious market. In most sectors, that kind of upside is almost unheard of. Some biotech stocks...
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
Health care stocks were leaning lower premarket Wednesday, with the State Street Health Care Select PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Get Arcturus Therapeutics Holdings Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
